SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.
SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 20, 2022 | Seed | $4M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Savantus Ventures | — | Seed |